Picture of Solasia Pharma KK logo

4597 — Solasia Pharma KK News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Table: Solasia Pharma -2024 parent results

Feb 12 (Reuters)- 
          Solasia Pharma K. K. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2024    Dec 31, 2023   Dec 31, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            316 mln         617 mln                               
                 (-48.7 pct)     (-43.5 pct)                             
  Operating     loss 840 mln    loss 688 mln                             
  Recurring     loss 869 mln    loss 678 mln                             
  Net           loss 868 mln    loss 679 mln                             
  EPS           loss 4.37 yen   loss 4.04 yen                            
  EPS Diluted   loss 4.37 yen   loss 4.04 yen                            
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - Solasia Pharma K. K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T

Recent news on Solasia Pharma KK

See all news